Investment House LLC lowered its position in shares of Stryker Corporation (NYSE:SYK) by 1.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,781 shares of the medical technology company’s stock after selling 400 shares during the period. Investment House LLC’s holdings in Stryker Corporation were worth $5,369,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Thrivent Financial for Lutherans raised its position in shares of Stryker Corporation by 5.1% in the fourth quarter. Thrivent Financial for Lutherans now owns 13,740 shares of the medical technology company’s stock valued at $1,640,000 after buying an additional 670 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in Stryker Corporation by 1.7% in the fourth quarter. UBS Asset Management Americas Inc. now owns 929,571 shares of the medical technology company’s stock worth $111,370,000 after buying an additional 15,523 shares in the last quarter. M Holdings Securities Inc. raised its position in Stryker Corporation by 10.9% in the fourth quarter. M Holdings Securities Inc. now owns 8,074 shares of the medical technology company’s stock worth $967,000 after buying an additional 793 shares in the last quarter. Becker Capital Management Inc. raised its position in Stryker Corporation by 6.6% in the fourth quarter. Becker Capital Management Inc. now owns 3,222 shares of the medical technology company’s stock worth $386,000 after buying an additional 200 shares in the last quarter. Finally, Teachers Advisors LLC increased its stake in shares of Stryker Corporation by 5.7% in the fourth quarter. Teachers Advisors LLC now owns 377,336 shares of the medical technology company’s stock valued at $45,209,000 after buying an additional 20,450 shares during the last quarter. Institutional investors own 73.99% of the company’s stock.
Stryker Corporation (NYSE:SYK) traded down 0.40% during trading on Tuesday, hitting $146.14. The company had a trading volume of 644,974 shares. The stock has a market capitalization of $54.67 billion, a PE ratio of 32.62 and a beta of 0.80. The stock has a 50-day moving average of $143.16 and a 200-day moving average of $134.68. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84.
Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. During the same quarter last year, the company posted $1.39 EPS. The business’s quarterly revenue was up 6.1% on a year-over-year basis. On average, equities analysts anticipate that Stryker Corporation will post $6.50 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is currently 37.95%.
TRADEMARK VIOLATION WARNING: “Stryker Corporation (NYSE:SYK) Stake Cut by Investment House LLC” was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2017/08/08/stryker-corporation-nysesyk-stake-lowered-by-investment-house-llc-updated-updated-updated.html.
Several brokerages have weighed in on SYK. BMO Capital Markets reaffirmed a “hold” rating and set a $125.00 target price on shares of Stryker Corporation in a research report on Tuesday, April 11th. Jefferies Group LLC reaffirmed a “hold” rating and set a $132.00 target price on shares of Stryker Corporation in a research report on Thursday, April 13th. BidaskClub lowered Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $148.00 target price on shares of Stryker Corporation in a research report on Monday, April 17th. Finally, Barclays PLC reaffirmed a “sell” rating and set a $133.00 target price on shares of Stryker Corporation in a research report on Thursday, April 27th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $144.03.
In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the sale, the insider now owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider David Floyd sold 7,381 shares of the firm’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $144.70, for a total transaction of $1,068,030.70. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 31,686 shares of company stock worth $4,590,562. 7.40% of the stock is owned by insiders.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.